Teva Pharma (TEVA) PT Lowered to $20 at Wells Fargo
Tweet
Share
E-mail
Get Alerts TEVA Hot Sheet
Price: $36.62 -2.32%
Rating Summary:
17 Buy, 22 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 18 | New: 28
Rating Summary:
17 Buy, 22 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 18 | New: 28
Join SI Premium – FREE
Wells Fargo analyst David Maris lowered the price target on Teva Pharma (NYSE: TEVA) to $20.00 (from $24.00) while maintaining a Market Perform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Teva in talks with Trump administration on Medicaid drug pricing
- Dycom Industries (DY) PT Lowered to $375 at Raymond James
- JPMorgan Upgrades Cosmo Energy Holdings (5021:JP) to Overweight
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Wells Fargo, David MarisSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
